Analysts highlighted the imaging giant's “strong” competitive position, multifaceted revenue streams through the delivery of various imaging modalities, and payer diversity.
Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD, during day 2 of ACC.22.
Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time.
Those who received customized messages pertaining to their risk of developing colorectal cancer are 34% more likely to complete the screening than those who are offered standard referrals, research shows.
The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.
For patients who have suffered an acute ischemic stroke, white matter hyperintensity visualized on MRI before thrombectomy might be indicative of poor post-procedure clinical outcomes.
Experts urged physicians to take extra protective measures when in the presence of metal protheses during procedures and to be vigilant in shielding their eyes from additional exposure.
More than 6,000 IN.PACT Admiral Drug-Coated Balloons have been recalled, Medtronic announced Thursday.
The issue, identified during a routine inspection, appears to be related to a change in the manufacturing process. It has now been corrected, Medtronic said in a statement.